Sign In

Tina Raine-Bennett, MD, MPH

People

Kaiser Permanente Division of Research
2000 Broadway
Oakland, CA 94612

(510) 891-5930 (phone)
tina.r.raine-bennett@kp.org
Kaiser Permanente Researcher Profiles


 
Tina Raine-Bennett, MD, MPH, is a senior research scientist at the Kaiser Permanente Northern California Division of Research and the research director of the Women's Health Research Institute. She received her medical training at the University of California, San Diego and post-graduate residency training and MPH at the University of Washington in Seattle, where she also completed a Robert Wood Johnson Clinical Scholars Fellowship. She is a board certified obstetrician-gynecologist with special interest in adolescent risk behaviors and reproductive health. Prior to coming to the Division of Research, Dr. Raine-Bennett was a professor in the Department of Obstetrics, Gynecology, and Reproductive Sciences at University of California, San Francisco (UCSF). She was based at San Francisco General Hospital where she was also the medical director of the New Generation Health Center, a UCSF affiliate site that seeks to help teens and young women avoid unintended pregnancy. Dr. Raine-Bennett's research has focused on elucidating factors that influence contraceptive choice and continuation and she is principal investigator on NIH grants to assess hormonal contraceptive use in high-risk women and develop interventions to improve contraceptive use. Her past and current research on emergency contraception has focused on the safety of making emergency contraception more accessible and she recently completed an industry trial to make emergency contraception available to teens without a prescription. She served on the editorial board of Obstetrics and Gynecology and is currently a reviewer for the journal. She is an examiner for the American Board of Obstetrics and Gynecology and also serves on national committees for the American College of Obstetrics and Gynecology and the National Medical Board of Planned Parenthood Federation of America. In her position as research director of the Women's Health Research Institute, Dr. Raine-Bennett focuses on expanding research on women's health within the Division and translating women's health research into clinical practice within the Ob/Gyn departments in Northern California. She also promotes the involvement of clinicians in research designed to improve the health outcomes and health care experiences of women at Kaiser Permanente and women in general.

Current Position(s):

  • Research Scientist III, Division of Research, Kaiser Permanente Northern California
  • Staff Physician, Kaiser Permanente Medical Center, Oakland, California
  • Volunteer Clinical Professor of Obstetrics Gynecology and Reproductive Sciences, UCSF

Section Affiliations:

Primary Research Interests:

  • Interventions to reduce adolescent and unintended pregnancy
  • Disparities in reproductive health
  • Primary prevention in women's health
  • Comparative effectiveness of procedures to treat gynecologic problems

    Incidence and Trend of Ectopic Pregnancy and Contraceptive Use

    ​Incidence and management of ectopic pregnancy have undergone significant changes in recent decades. There is a general consensus that available effective contraceptive methods reduce the absolute risk of ectopic pregnancy. Ectopic pregnancy incidence rate has not been well-documented in the last decade, and the mix of methods of contraceptives used has changed significantly over this time period.  The goal of this project is to assess the feasibility of and generate data using electronic health records on ectopic pregnancy incidence, risk factors, and management trends in the general population and in women using select contraceptive methods, particularly intrauterine devices.


    Investigator: Raine-Bennett, Tina
    Funder: Bayer AG

    Incidence of Osteoporosis and Abnormal Lipid Profiles in Women Over Age 40, Who Test Positive for a BRCA1 or BRCA2 Mutation and Have Had a Risk-Reducing Salpingo-oophorectomy

    This cohort study will use DXA scans to: 1) establish the incidence of abnormal DXA scans in women post testing positive for BRCA1 or 2 mutations who have undergone risk-reducing salpingo-oophorectomy (RRSO); and 2) identify risk factors for abnormal DXA tests. The study will also examine lipid profiles to: 1) establish the incidence of abnormal lipid profiles in women post testing positive for BRCA1 or 2 mutations who have undergone RRSO; and 2) identify risk factors for abnormal lipid profiles. Secondary aims are to evaluate the incidence of adverse health outcomes in women with BRCA mutations, undergoing RRSO, including sexual dysfunction, menopausal symptoms, increase in BMI, development of hypertension, hyperlipidemia, diabetes, depression, new cancers, including BRCA-related (ovary/peritoneal, breast, melanoma) and other cancers, and identify risk factors which are associated with adverse outcomes.
    Investigator: Raine-Bennett, Tina
    Funder: Kaiser Permanente Institutional Planned Giving

    Contraceptive Clinical Trials Network

    The NICHD Contraceptive Clinical Trials Network (CCTN) will consist of up to 16 sites capable of performing female contraceptive clinical trials. Each site will work with the CCTN Statistical and Clinical Coordinating Center and NICHD to rapidly develop protocols and initiate clinical trials. The CCTN sites contractors will evaluate systematically the safety and efficacy of new female contraceptive drugs and devices as well as drug treatments of gynecologic conditions.
    Investigator: Raine-Bennett, Tina
    Funder: National Institute of Child Health and Human Development

    Occult Uterine Sarcoma and Leiomyosarcoma: Incidence of and Survival Associated With Morcellation

    Author(s): Raine-Bennett T1; Tucker LY; Zaritsky E; Littell RD; Palen T; Neugebauer R; Axtell A; Schultze PM; Kronbach DW; Embry-Schubert J; Sundang A; Bischoff K; Compton-Phillips AL; Lentz SE;

    ​​Obstet Gynecol. 2016 Jan;127(1):29-39. doi: 10.1097/AOG.0000000000001187.

    PubMed abstract

    Reproductive health outcomes of insured adolescent and adult women who access oral levonorgestrel emergency contraception

    Author(s): Raine-Bennett T; Merchant M; Sinclair F; Lee JW; Goler N

    Obstet Gynecol. 2015 Apr;125(4):904-11.

    PubMed abstract

    An Over-the-Counter Simulation Study of a Single-Tablet Emergency Contraceptive in Young Females

    Author(s): Raine TR; Ricciotti N; Sokoloff A; Brown BA; Hummel A; Harper CC

    Obstet Gynecol. 2012 Apr;119(4):772-9.

    PubMed abstract

    Risk of cardiovascular disease in women with BRCA1 and BRCA2 mutations

    Author(s): Powell CB; Alabaster A; Armstrong MA; Stoller N; Raine-Bennett T

    Gynecol Oncol. 2018 Oct 09.

    PubMed abstract

    Contraception after Abortion and Risk of Repeated Unintended Pregnancy among Health Plan Members

    Author(s): Postlethwaite D; Merchant M; Alabaster A; Raine-Bennett T

    Perm J. 2018 Sep 10;22. Epub 2018-09-10.

    PubMed abstract

    Scientific abstracts featured research at the 2018 North American Forum on Family Planning

    Author(s): Teal S; Borrero S; Hubacher D; Madden T; Raine-Bennett T

    Contraception. 2018 Jul 19.

    PubMed abstract

    The Relationship Between Prescription Copayments and Contraceptive Adherence in a New-user Cohort

    Author(s): Marshall C; Schmittdiel J; Chandra M; Calhoun A; Raine-Bennett T

    Med Care. 2018 May 29.

    PubMed abstract

    Recent Intrauterine device use and the risk of precancerous cervical lesions and cervical cancer

    Author(s): Averbach S; Silverberg MJ; Leyden W; Smith-McCune K; Raine-Bennett T; Sawaya GF

    Contraception. 2018 Apr 16.

    PubMed abstract

    Automated Cervical Screening and Triage, Based on HPV Testing and Computer-Interpreted Cytology

    Author(s): Yu K; Raine-Bennett TR; Schiffman M; et al.

    J Natl Cancer Inst. 2018 Apr 11.

    PubMed abstract

    Bone loss in women with BRCA1 and BRCA2 mutations

    Author(s): Powell CB; Alabaster A; Stoller N; Armstrong MA; Salyer C; Hamilton I; Raine-Bennett T

    Gynecol Oncol. 2018 Mar;148(3):535-539.

    PubMed abstract

    Validation of an HPV DNA cervical screening test that provides expanded HPV typing

    Author(s): Demarco M; Fetterman B; Lorey T; Poitras N; Raine-Bennett TR; Schiffman M; et al.

    J Clin Microbiol. 2018 Feb 28.

    PubMed abstract

    Human Papillomavirus DNA methylation as a biomarker for cervical precancer: Consistency across 12 genotypes and potential impact on management of HPV-positive women

    Author(s): Clarke MA; Gradíssimo A; Schiffman M; Lam J; Sollecito CC; Fetterman B; Lorey T; Poitras NE; Raine-Bennett T; Castle PE; Wentzensen N; Burk RD

    Clin Cancer Res. 2018 Feb 02.

    PubMed abstract

    Exploring young women's decisional needs for contraceptive method choice: A qualitative study

    Author(s): Marshall C; Kandahari N; Raine-Bennett T

    Contraception. 2017 Oct 13.

    PubMed abstract

    HPV16 E7 Genetic Conservation Is Critical to Carcinogenesis

    Author(s): Mirabello L; Yeager M; Yu K; Clifford GM; Xiao Y; Zhu B; Cullen M; Boland JF; Wentzensen N; Nelson CW; Raine-Bennett T; Chen Z; Bass S; Song L; Yang Q; Steinberg M; Burdett L; Dean M; Roberson D; Mitchell J; Lorey T; Franceschi S; Castle PE; Walker J; Zuna R; Kreimer AR; Beachler DC; Hildesheim A; Gonzalez P; Porras C; Burk RD; Schiffman M

    Cell. 2017 Sep 07;170(6):1164-1174.e6.

    PubMed abstract

    Scientific abstracts featured research at the 2017 North American Forum on Family Planning

    Author(s): Espey E; Teal S; Borrero S; Raine-Bennett T; Finer L

    Contraception. 2017 Aug 01.

    PubMed abstract

    Adjuvant gemcitabine-docetaxel chemotherapy for stage I uterine leiomyosarcoma: Trends and survival outcomes

    Author(s): Littell RD; Tucker LY; Raine-Bennett T; Palen TE; Zaritsky E; Neugebauer R; Embry-Schubert J; Lentz SE

    Gynecol Oncol. 2017 Jul 24.

    PubMed abstract

    Association of Multiple Primary Skin Cancers With Human Immunodeficiency Virus Infection, CD4 Count, and Viral Load

    Author(s): Asgari MM; Ray GT; Quesenberry CP; Katz KA; Silverberg MJ

    JAMA Dermatol. 2017 Jul 12.

    PubMed abstract

    Minimally Invasive Hysterectomy and Power Morcellation Trends in a West Coast Integrated Health System

    Author(s): Zaritsky E; Tucker LY; Neugebauer R; Chou T; Flanagan T; Walter AJ; Raine-Bennett T

    Obstet Gynecol. 2017 Jun;129(6):996-1005.

    PubMed abstract

    Over-the-Counter Access to Oral Contraceptives for Adolescents

    Author(s): Upadhya KK; Santelli JS; Raine-Bennett TR; Kottke MJ; Grossman D

    J Adolesc Health. 2017 Mar 06.

    PubMed abstract

    Deep sequencing of HPV16 genomes: A new high-throughput tool for exploring the carcinogenicity and natural history of HPV16 infection

    Author(s): Cullen M; Boland JF; Schiffman M; Zhang X; Wentzensen N; Yang Q; Chen Z; Yu K; Mitchell J; Roberson D; Bass S; Burdette L; Machado M; Ravichandran S; Luke B; Machiela MJ; Andersen M; Osentoski M; Laptewicz M; Wacholder S; Feldman A; Raine-Bennett T; Lorey T; Castle PE; Yeager M; Burk RD; Mirabello L

    Papillomavirus Res. 2015 Dec 1;1:3-11.

    PubMed abstract

    HPV16 Sublineage Associations With Histology-Specific Cancer Risk Using HPV Whole-Genome Sequences in 3200 Women

    Author(s): Mirabello L; Yeager M; Cullen M; Boland JF; Chen Z; Wentzensen N; Zhang X; Yu K; Yang Q; Mitchell J; Roberson D; Bass S; Xiao Y; Burdett L; Raine-Bennett T; Lorey T; Castle PE; Burk RD; Schiffman M

    J Natl Cancer Inst. 2016 Sep;108(9). Epub 2016-04-29.

    PubMed abstract

    Patient perceptions of a decision support tool to assist with young women's contraceptive choice

    Author(s): Marshall C; Nuru-Jeter A; Guendelman S; Mauldon J; Raine-Bennett T

    Patient Educ Couns. 2016 Aug 24.

    PubMed abstract

    Experience With Opportunistic Salpingectomy in a Large, Community-Based Health System in the United States

    Author(s): Garcia C; Martin M; Tucker LY; Lyon L; Armstrong MA; McBride-Allen S; Littell RD; Alabaster A; Raine-Bennett T; Powell CB

    Obstet Gynecol. 2016 Aug;128(2):277-83.

    PubMed abstract

    Featured research at the 2015 North American Forum on Family Planning

    Author(s): Bruce L; Espey E; Borrero S; Raine-Bennett T; Finer L; Teal S

    Contraception. 2015 Jul 2.

    PubMed abstract

    The role of human papillomavirus (HPV) genotyping in cervical cancer screening: A large-scale evaluation of the cobas HPV test

    Author(s): Schiffman M; Boyle S; Raine-Bennett T; Katki HA; Gage JC; Wentzensen N; Kornegay JR; Apple R; Aldrich C; Ehrlich HA; Tam T; Befano B; Burk RD; Castle PE

    Cancer Epidemiol Biomarkers Prev. 2015 Jun 18.

    PubMed abstract

    Development of a Brief Questionnaire to Assess Contraceptive Intent

    Author(s): Raine-Bennett TR; Rocca CH

    Patient Educ Couns. 2015 Jun 3.

    PubMed abstract

    Improved Perinatal Depression Screening, Treatment, and Outcomes With a Universal Obstetric Program

    Author(s): Avalos LA; Raine-Bennett T; Chen H; Adams AS; Flanagan T

    Obstet Gynecol. 2016 May;127(5):917-25.

    PubMed abstract

    HPV16 methyl-haplotypes determined by a novel next-generation sequencing method are associated with cervical precancer

    Author(s): Mirabello L; Frimer M; Harari A; McAndrew T; Smith B; Chen Z; Wentzensen N; Wacholder S; Castle PE; Raine-Bennett T; Schiffman M; Burk RD

    Int J Cancer. 2015 Feb 15;136(4):E146-53. Epub 2014-09-03.

    PubMed abstract

    Occult Uterine Sarcoma and Leiomyosarcoma: Incidence of and Survival Associated With Morcellation

    Author(s): Raine-Bennett T1; Tucker LY; Zaritsky E; Littell RD; Palen T; Neugebauer R; Axtell A; Schultze PM; Kronbach DW; Embry-Schubert J; Sundang A; Bischoff K; Compton-Phillips AL; Lentz SE;

    ​​Obstet Gynecol. 2016 Jan;127(1):29-39. doi: 10.1097/AOG.0000000000001187.

    PubMed abstract

    A study of HPV typing for the management of HPV-positive ASC-US cervical cytologic results

    Author(s): Schiffman M; Vaughan LM; Raine-Bennett TR; Castle PE; Katki HA; Gage JC; Fetterman B; Befano B; Wentzensen N

    Gynecol Oncol. 2015 Sep;138(3):573-8. Epub 2015-07-04.

    PubMed abstract

    Reproductive health outcomes of insured adolescent and adult women who access oral levonorgestrel emergency contraception

    Author(s): Raine-Bennett T; Merchant M; Sinclair F; Lee JW; Goler N

    Obstet Gynecol. 2015 Apr;125(4):904-11.

    PubMed abstract

    A STUDY OF GENOTYPING FOR THE MANAGEMENT OF HUMAN PAPILLOMAVIRUS-POSITIVE, CYTOLOGY-NEGATIVE CERVICAL SCREENING RESULTS

    Author(s): Schiffman M; Burk RD; Boyle S; Raine-Bennett T; Katki HA; Gage JC; Wentzensen N; Kornegay JR; Aldrich C; Tam T; Erlich H; Apple R; Befano B; Castle PE

    J Clin Microbiol. 2015 Jan;53(1):52-9. Epub 2014-10-22.

    PubMed abstract

    Risk management options elected by women after testing positive for a BRCA mutation

    Author(s): Garcia C; Wendt J; Lyon L; Jones J; Littell RD; Armstrong MA; Raine-Bennett T; Powell CB

    Gynecol Oncol. 2014 Feb;132(2):428-33. Epub 2013-12-16.

    PubMed abstract

    Counseling and provision of long-acting reversible contraception in the US: National survey of nurse practitioners

    Author(s): Harper CC; Stratton L; Raine TR; Thompson K; Henderson JT; Blum M; Postlethwaite D; Speidel JJ

    Prev Med. 2013 Dec;57(6):883-8. Epub 2013-10-12.

    PubMed abstract

    Evaluation of e-mail contact to conduct follow-up among adolescent women participating in a longitudinal cohort study of contraceptive use

    Author(s): Haider S; Dodge LE; Brown BA; Hacker MR; Raine TR

    Contraception. 2013 Jul;88(1):18-23. Epub 2013-01-03.

    PubMed abstract

    Five-year risks of CIN 2+ and CIN 3+ among women with HPV-positive and HPV-negative LSIL Pap results

    Author(s): Katki HA; Schiffman M; Castle PE; Fetterman B; Poitras NE; Lorey T; Cheung LC; Raine-Bennett T; Gage JC; Kinney WK

    J Low Genit Tract Dis. 2013 Apr;17(5 Suppl 1):S43-9.

    PubMed abstract

    Benchmarking CIN 3+ risk as the basis for incorporating HPV and Pap cotesting into cervical screening and management guidelines

    Author(s): Katki HA; Schiffman M; Castle PE; Fetterman B; Poitras NE; Lorey T; Cheung LC; Raine-Bennett T; Gage JC; Kinney WK

    J Low Genit Tract Dis. 2013 Apr;17(5 Suppl 1):S28-35.

    PubMed abstract

    Five-year risks of CIN 3+ and cervical cancer among women with HPV testing of ASC-US Pap results

    Author(s): Katki HA; Schiffman M; Castle PE; Fetterman B; Poitras NE; Lorey T; Cheung LC; Raine-Bennett T; Gage JC; Kinney WK

    J Low Genit Tract Dis. 2013 Apr;17(5 Suppl 1):S36-42.

    PubMed abstract

    Five-year risk of CIN 3+ to guide the management of women aged 21 to 24 years

    Author(s): Katki HA; Schiffman M; Castle PE; Fetterman B; Poitras NE; Lorey T; Cheung LC; Raine-Bennett T; Gage JC; Kinney WK

    J Low Genit Tract Dis. 2013 Apr;17(5 Suppl 1):S64-8.

    PubMed abstract

    Five-year risk of recurrence after treatment of CIN 2, CIN 3, or AIS: performance of HPV and Pap cotesting in posttreatment management

    Author(s): Katki HA; Schiffman M; Castle PE; Fetterman B; Poitras NE; Lorey T; Cheung LC; Raine-Bennett T; Gage JC; Kinney WK

    J Low Genit Tract Dis. 2013 Apr;17(5 Suppl 1):S78-84.

    PubMed abstract

    Follow-up testing after colposcopy: five-year risk of CIN 2+ after a colposcopic diagnosis of CIN 1 or less

    Author(s): Katki HA; Gage JC; Schiffman M; Castle PE; Fetterman B; Poitras NE; Lorey T; Cheung LC; Raine-Bennett T; Kinney WK

    J Low Genit Tract Dis. 2013 Apr;17(5 Suppl 1):S69-77.

    PubMed abstract

    Five-year risks of CIN 3+ and cervical cancer among women with HPV-positive and HPV-negative high-grade Pap results

    Author(s): Katki HA; Schiffman M; Castle PE; Fetterman B; Poitras NE; Lorey T; Cheung LC; Raine-Bennett T; Gage JC; Kinney WK

    J Low Genit Tract Dis. 2013 Apr;17(5 Suppl 1):S50-5.

    PubMed abstract

    'Do ask, do provide' contraception for women in the u.s. Military

    Author(s): Raine-Bennett T

    Obstet Gynecol. 2013 Feb;121(2 Pt 1):229-30.

    PubMed abstract

    With pills, patches, rings, and shots: who still uses condoms? A longitudinal cohort study

    Author(s): Goldstein RL; Upadhyay UD; Raine TR

    J Adolesc Health. 2013 Jan;52(1):77-82. Epub 2012 Oct 8.

    PubMed abstract

    An Over-the-Counter Simulation Study of a Single-Tablet Emergency Contraceptive in Young Females

    Author(s): Raine TR; Ricciotti N; Sokoloff A; Brown BA; Hummel A; Harper CC

    Obstet Gynecol. 2012 Apr;119(4):772-9.

    PubMed abstract